A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy

scientific article published on 22 April 2019

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/JPM9020019
P932PMC publication ID6617187
P698PubMed publication ID31013571

P50authorMichael W KattanQ60653077
Jan VerbeekQ51611013
Ewout W. SteyerbergQ37828851
P2093author name stringMonique J Roobol
Chris Parker
Daan Nieboer
P2860cites workMRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.Q52649258
Estimation in a competing risks proportional hazards model under length-biased sampling with censoring.Q53115553
Reporting and Interpreting Decision Curve Analysis: A Guide for InvestigatorsQ62673865
Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-upQ63965969
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effectsQ64120111
The impact of co-morbidity on life expectancy among men with localized prostate cancerQ71122151
The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction modelsQ92058018
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentQ38939206
The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and CommentQ39233902
Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation studyQ39738179
Assessing individual risk for prostate cancerQ39809092
A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.Q39899527
Follow-up of Prostatectomy versus Observation for Early Prostate CancerQ40125644
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.Q45112412
Implications of the new AUA guidelines on prostate cancer detection in the U.S.Q46619813
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortalityQ47288274
Next-generation prostate cancer risk calculator for primary care physiciansQ47704685
Screening for prostate cancerQ24201690
Overdiagnosis and overtreatment of prostate cancerQ26859596
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerQ28005473
Screening and prostate-cancer mortality in a randomized European studyQ29617485
Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancerQ33672510
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.Q34041688
Impact of comorbidity on survival among men with localized prostate cancerQ34879348
The Global Burden of Cancer 2013Q35847426
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.Q35875135
Successful external validation of a model to predict other cause mortality in localized prostate cancerQ35918818
20-year outcomes following conservative management of clinically localized prostate cancerQ36115855
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectdecision makingQ1331926
shared decision-makingQ7489544
P304page(s)19
P577publication date2019-04-22
P1433published inJournal of personalized medicineQ27724740
P1476titleA Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
P478volume9

Search more.